Table 1.
Baseline clinical characteristics of 137 subjects
| Characteristic | Value |
|---|---|
| Age, yr | 46.8 ± 16.3 |
| Sex, male | 67 (48.9) |
| Body mass index, kg/m2 | 23.1 ± 3.6 |
| Comorbid conditions | |
| IMIDs | 85 (62.0) |
| Diabetes mellitus | 6 (4.4) |
| Malignancy | 6 (4.4) |
| Organ transplant recipient | 2 (1.5) |
| Previous history of anti-TB treatment | 10 (7.3) |
| Positive BCG scarring | 111 (81.0) |
| Immunocompromiseda | 64 (46.7) |
| TB infection risk group | |
| Active TB | 14 (10.2) |
| Recent TB contact | 14 (10.2) |
| LTBI screening before biologic therapy | 85 (62.0) |
| Other diseases | 24 (17.5) |
Values are presented as mean ± SD or number (%).
IMID, immune-mediated inflammatory disease; TB, tuberculosis; BCG, bacillus calmette-guérin; LTBI, latent tuberculosis infection.
a
Causes of immunosuppression included diabetes mellitus, chronic kidney disease, malignancy, organ transplantation, human immunodeficiency virus, immunosuppressive medications or steroids (prednisolone 15 mg/day for > 1 month).